Neurological & Neuromodulation Devices
Manufacturers of deep brain stimulators, spinal cord stimulators, and neuromodulation therapy devices.
- 5
- Verticals
Overview
Neurological & Neuromodulation Devices covers manufacturers of deep-brain stimulators, spinal-cord stimulators, and neuromodulation therapy devices. It is an innovation-driven category led by Medtronic, Abbott, and Boston Scientific, with applications expanding across chronic pain, movement disorders, and emerging indications.
Demand is supported by chronic-pain prevalence and expanding neuromodulation indications, and the category combines implantable devices with recurring programming and replacement. It is consolidated and high-value, sitting within broad electromedical-apparatus manufacturing in the federal data.
Market snapshot
Within electromedical apparatus (NAICS 334510); the Census Bureau does not split out neuromodulation, so the segment is not separately sized.
Business model & economics
Revenue model
Implantable device sales plus replacement and programming
Key economics
- Recurring revenue
- Moderate
- EBITDA margin
- 20–30%
- Capex intensity
- High
replacement-cycle-driven
Characteristics
- Chronic-pain and movement-disorder applications.
- Expanding neuromodulation indications.
- Implantables with replacement-cycle revenue.
M&A deal context
Who’s acquiring
- Neuromodulation strategics
- Diversified medtech platforms
- VC-backed innovators
What’s driving deals
- Acquisition of neuromodulation innovation.
- Expanding indications and chronic-pain demand.
- High-value implantable economics.
Verticals in this segment
Find Neurological & Neuromodulation Devices acquisition targets
Search Acquisera’s index for companies classified under Neurological & Neuromodulation Devices (4.8.8) and build a targeted deal pipeline.
Search companies